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Background: What do we
know about Clinical trials?
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cancer. I also read a few lung cancer-

trials. ClinicalTrials.gov is a database

related medical publications, which gave
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Fig. 1 100 RedCap Lung cancer trial surveys eligibility
categorical measures comparison among categories on a range
of levels of difficulty.

categories that are evidently listed are the ones
one can comprehend the most. As a result of
our data, I believe that the eligibility criteria

Level of difficulty (easiest to hardest)
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To keep the eligibility criteria section simple:
medical jargon should be avoided. I believe if

43%- were in the range of difficulty
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Fig. 2 My comprehension levels representing on 100 clinical
trials eligibility criteria.

The majority of clinical trials- a total of
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are eligible for specific trials. The public's

understanding of the clinical trial eligibility

with little to no deep scientific understanding.

Eligibility survey measures
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syntax and readability, it might be difficult

be improved because it is hard to understand
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clinical trial information and assists
researchers with participant recruitment.

If you do not have an extensive scientific

should be standardized in order to increase the
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number of qualifying patients enrolled in
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clinical trials. Fewer than 1 in 20 adult cancer
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Using the eligibility NCI survey on Redcap,
we will decode 100 clinical trials on lung
cancer from clinicaltrials.gov. The survey

asks a series of questions about eligibility to
determine which patients are eligible for the
study. The comprehensibility of the

eligibility criteria is assessed using
categorical and numerical measures about
cancer stage, metastatic role, biomarkers,

therapies, age, gender, and performance
status.

Results

Based on my data, age, therapies, cancer stage,
and gender were the most straightforward
requirements to understand from the webpage.

and the role of metastases to be the most
difficult to comprehend because of my lack-
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is level 5- the most arduous level of difficulty.
One of the factors that may influence this is that

clinicaltirals.gov is not very direct when it
comes to biomarkers, performance status, and
metastatic role. Unlike the easiest measures that

I understood, the information for the more
challenging categories was scattered throughout
the page. The most comprehensive categories

have a mean of level 1, which is the easiest level
of understanding. Our findings imply that non-

readability inconsistencies.

clinical trials, but with clear information

cancer patients can potentially increase that

The mean value for these categories in this data

experts reading eligibility criteria have many
As a high school student, I found biomarkers

patients enroll in cancer clinical trials.

Slightly disagree

Fig. 3 Graph represents my confidence level regarding my
accuracy of the 100 surveys coded.

statistic.

After completing a survey for a clinical trial,

I use a scale of Strongly Agree to Strongly
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